Sarepta Therapeutics, Inc. (SRPT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 03:22PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 12.36B |
| Enterprise Value | 12.08B |
| Trailing P/E | N/A |
| Forward P/E | 46.30 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.72 |
| Price/Book (mrq) | 14.38 |
| Enterprise Value/Revenue | 8.61 |
| Enterprise Value/EBITDA | 126.15 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change 3 | 0.56% |
| S&P500 52-Week Change 3 | 23.57% |
| 52 Week High 3 | 159.89 |
| 52 Week Low 3 | 55.25 |
| 50-Day Moving Average 3 | 125.83 |
| 200-Day Moving Average 3 | 111.95 |
Share Statistics
| Avg Vol (3 month) 3 | 854.57k |
| Avg Vol (10 day) 3 | 1.03M |
| Shares Outstanding 5 | 94.51M |
| Implied Shares Outstanding 6 | 93.86M |
| Float 8 | 90.36M |
| % Held by Insiders 1 | 4.40% |
| % Held by Institutions 1 | 87.03% |
| Shares Short (Apr 15, 2024) 4 | 4.87M |
| Short Ratio (Apr 15, 2024) 4 | 7.68 |
| Short % of Float (Apr 15, 2024) 4 | 5.42% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 5.19% |
| Shares Short (prior month Mar 15, 2024) 4 | 4.97M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:6 |
| Last Split Date 3 | Jul 12, 2012 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 1.20% |
| Operating Margin (ttm) | 8.44% |
Management Effectiveness
| Return on Assets (ttm) | -1.89% |
| Return on Equity (ttm) | 2.02% |
Income Statement
| Revenue (ttm) | 1.4B |
| Revenue Per Share (ttm) | 14.95 |
| Quarterly Revenue Growth (yoy) | 63.10% |
| Gross Profit (ttm) | N/A |
| EBITDA | -52.99M |
| Net Income Avi to Common (ttm) | 16.9M |
| Diluted EPS (ttm) | -5.81 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.39B |
| Total Cash Per Share (mrq) | 14.71 |
| Total Debt (mrq) | 1.4B |
| Total Debt/Equity (mrq) | 145.20% |
| Current Ratio (mrq) | 4.05 |
| Book Value Per Share (mrq) | 10.17 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -533.67M |
| Levered Free Cash Flow (ttm) | -367.38M |
© 2024 Yahoo. All rights reserved.